Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | RAF1 | P04049 | 12/20 | 0.41 |
| ▸ | BRAF | P15056 | 9/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.38 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.38 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isoxaben SCHEMBL9706966 | 1.00 | CYP1A2 (0.45) | CYP1A2CYP3A4CYP2C19RAF1BRAF | |
| Isoxaben SCHEMBL8539623 | 0.86 | CYP1A2 (0.53) | CYP1A2CYP3A4CYP2C19RAF1BRAF | |
| Isoxaben SCHEMBL54432 | 0.86 | CYP1A2 (0.53) | CYP1A2CYP3A4CYP2C19RAF1BRAF | |
| Isoxaben SCHEMBL9713018 | 0.85 | CYP1A2 (0.52) | CYP1A2CYP3A4CYP2C19RAF1BRAF | |
| Isoxaben SCHEMBL10534875 | 0.84 | RAF1 (0.36) | RAF1BRAF | |
| Isoxaben SCHEMBL9715108 | 0.84 | RAF1 (0.36) | RAF1BRAF | |
| Isoxaben SCHEMBL9270606 | 0.82 | RAF1 (0.33) | CYP1A2CYP3A4CYP2C19RAF1BRAF | |
| Isoxaben SCHEMBL8339490 | 0.81 | CYP1A2 (0.43) | CYP1A2CYP3A4CYP2C19RAF1BRAF | |
| SCHEMBL16589802 | 0.80 | TAS1R3 (0.51) | CYP1A2CYP3A4CYP2C19RAF1BRAF | |
| SCHEMBL9713569 | 0.80 | CYP1A2 (0.46) | CYP1A2CYP3A4CYP2C19RAF1BRAF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2961273-A1 | SYNERGIC HERBICIDE COMPOSITIONS | Arysta Lifescience (FR) | 2016-01-06 | — | — | EP | claimed |
| WO-2014131958-A1 | SYNERGIC HERBICIDE COMPOSITIONS | ARYSTA LIFESCIENCE (FR) | 2014-09-04 | — | — | WO | claimed |
| US-20050250647-A1 | Herbicide combination | BAYER CROPSCIENCE GMBH (DE) | 2005-11-10 | — | — | US | claimed |
| WO-2004067527-A1 | THIOPHENE DERIVATIVES AS MICROBICIDES AND HERBICIDES | BAYER CROPSCIENCE AG (DE) | 2004-08-12 | — | — | WO | disclosed |
| CN-1046280-C | Novel thiophenesulfonylurea derivative and herbicidal composition containing the same | KOREA RES INST CHEM TECH (KR) | 1999-11-10 | — | — | CN | disclosed |
| CN-1134701-A | Novel thiophenesulfonylurea derivatives and herbicidal compositions containing the same | KOREA RES INST CHEM TECH (KR) | 1996-10-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050250647-A1 | Herbicide combination | DDT, MSRB3, MTX2 | CYP1A2 25/4885CYP3A4 151/4885CYP2C19 487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.